the aid library

LIST OPTIONS

Filter

12294

Review on palliative care with focus on 18 high tuberculosis priority countries

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Tuberculosis (‎TB)‎ is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h... more

External Link

External Link (374)

Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis

Haakenstad A., Bintz C., Knight M., et al. Lancet Global Health (2023) CC

The COVID-19 pandemic disrupted health systems in 2020, but it is unclear how financial hardship due to out-of-pocket (OOP) health-care costs was affected. We analysed catastrophic health expenditure (CHE) in 2020 in five countries with available household expenditure data: Belarus, Mexico, Peru, R... more

External Link

External Link (83)

National spending on health by source for 184 countries between 2013 and 2040

Dieleman, J.; Templin, T.; Sadat, N. et al. (2016) CC

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at simi...lar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42–22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9–3·4) in high-income countries, 3·4% (2·4–4·2) in upper-middle-income countries, 3·0% (2·3–3·6) in lower-middle-income countries, and 2·4% (1·6–3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action. Funding Bill & Melinda Gates Foundation. more

Download (822)

View PDF (1974)

Community Perspectives about Ebola in Bong, Lofa and Montserrado Counties of Liberia: Results of a Qualitative Study. Preliminary Findings

Ministry of Health and the Social Mobilization Partnership, Liberia (2015)

External Link

Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017–2018

Sreenivasan, N.; Li, A.; Shiferaw, M. et al. Science Direct (2019) CC

Rabies is a neglected zoonotic disease with a global burden of approximately 59,000 human deaths a year. Once clinical symptoms appear, rabies is almost invariably fatal; however, with timely and appropriate post-exposure prophylaxis (PEP) consisting of wound washing, vaccine, and in some cases rabi... more

External Link

Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study

Haakenstad, A.; Moses, M.W.; Tao, T.; et al. (2019) CC

Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe... more

External Link

Development assistance for community health workers in 114 low-and middle-income countries, 2007-2017

Lu C.; Panial Palazuelos D.; Luan Y. et al. PUBMED (2020) CC

The objective is to estimate the level and trend of develoment assistance for comunity health worker related projects in low and middle income countries between 2007 and 2017

Download (288)

View PDF (584)

Integrated community case management of childhood illness in low and middle-income countries

Cochrane (2021) CC

Download (268)

View PDF (395)

Tracking development assistance for reproductive, maternal, newborn, child and adolescent health in conflictaffected countries

Li Z., Richter L., Lu C. BMJ Global Health (2019) CC

Little is known about the patterns of development assistance (DA) for each component of reproductive, maternal, newborn, child and adolescent health (RMNCAH) in conflict-affected countries nor about the DA allocation in relation to the burden of disease

External Link

The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016

GBD 2016 Alcohol and Drug Use Collaborator (2018) CC

a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Published:November 01, 2018DOI:https://doi.org/10.1016/S2215-0366(18)30337-7

The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions

Harding, J.L.; Wander, P.L.; Zhang, X.; et al. Diabete Care (2022) CC

The epidemiology of adult-onset type 1 diabetes (T1D) incidence is not well-characterized due to the historic focus on T1D as a childhood-onset disease.

External Link

2017 Guidelines for Arterial Hypertension Management in Primary Health Care in Portuguese Language Countries

Moraes de Oliveira, G et al (2017) CC

This article unites the latest guidelines on the management of arterial hypertension in primary health care in Portuguese speaking countries including Brazil, Angola, Mozambique, São Tomé e Príncipe, Cape Verde, among others.

Download (124)

View PDF (403)

Health workers’ adoption of digital health technology in low- and middle-income countries: a systematic review and meta-analysis

World Health Organization WHO (2025) C_WHO

Digital health technology can make health systems more efficient and sustainable, facilitating the provision of high-quality care across a wide range of contexts and for diverse population health needs. The pace of innovation in digital health is rapid and constant, with new interventions bein... more

External Link

Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries

Haldane, V., De Foo, C., Abdalla, S.M. et al. (2021) C1

Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y

External Link

Donor funding health policy and systems research in low- and middle-income countries: how much, from where and to whom

Grépin, K.; Pinkstaff C.B.; Z. C. Shroff et al. Health Research Policy and Systems (2017) C1

Background: The need for sufficient and reliable funding to support health policy and systems research (HPSR) in low- and middle-income countries (LMICs) has been widely recognised. Currently, most resources to support such activities come from traditional development assistance for health (DAH) don... more

Download (414)

View PDF (513)

Cameroon: Disability and rehabilitation status, review of disability issues and rehabilitation services in 29 African countries

World Health Organisation (WHO) (2004) C_WHO

External Link

Surveillance, prevention and control of leishmaniases in the European Union and its neighbouring countries

European Centre for disease prevention and control (ECDC) European Centre for disease prevention and control (ECDC) (2022) C_CDC

This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv... more

Download (305)

View PDF (346)

Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries

A. J. Flisher; K. Sorsdahl; S. Hatherill; et al. Plos Medicine (2010) CC

Published: February 23, 2010 https://doi.org/10.1371/journal.pmed.1000235 Volume 7 | Issue 2 | e1000235

Download (325)

View PDF (387)

Roadmap for introduction and roll‐out of Merck rVSV‐ZEBOV Ebola Virus Disease vaccine in African countries

World Health Organization WHO (2019) C_WHO

Revised working paper following AVAREF meeting February 2019. WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi... more

External Link

Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002–11, and requirements to meet 2015 targets

Floyd, K.; C. Fitzpatrick; A. Pantoja et al. Lancet Glob Health (2013) C2

Progress in tuberculosis control worldwide, including achievement of 2015 global targets, requires adequate financing sustained for many years. WHO began yearly monitoring of tuberculosis funding in 2002. We used data reported to WHO to analyse tuberculosis funding from governments and international... more